These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3489480)

  • 1. Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
    Rahman A; Joher A; Neefe JR
    Br J Cancer; 1986 Sep; 54(3):401-8. PubMed ID: 3489480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes.
    Rahman A; Ganjei A; Neefe JR
    Cancer Chemother Pharmacol; 1986; 16(1):28-34. PubMed ID: 3484382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.
    Rahman A; White G; More N; Schein PS
    Cancer Res; 1985 Feb; 45(2):796-803. PubMed ID: 3967247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
    Rahman A; Fumagalli A; Barbieri B; Schein PS; Casazza AM
    Cancer Chemother Pharmacol; 1986; 16(1):22-7. PubMed ID: 3940217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
    Rahman A; Carmichael D; Harris M; Roh JK
    Cancer Res; 1986 May; 46(5):2295-9. PubMed ID: 3697976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes.
    Bally MB; Nayar R; Masin D; Cullis PR; Mayer LD
    Cancer Chemother Pharmacol; 1990; 27(1):13-9. PubMed ID: 2245488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-induced chronic cardiotoxicity and its protection by liposomal administration.
    Rahman A; More N; Schein PS
    Cancer Res; 1982 May; 42(5):1817-25. PubMed ID: 7066898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity.
    Rahman A; Fumagalli A; Goodman A; Schein PS
    Semin Oncol; 1984 Dec; 11(4 Suppl 3):45-55. PubMed ID: 6594763
    [No Abstract]   [Full Text] [Related]  

  • 9. Attenuation of dermal toxicity of doxorubicin by liposome encapsulation.
    Forssen EA; Tökes ZA
    Cancer Treat Rep; 1983 May; 67(5):481-4. PubMed ID: 6850663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.
    Gabizon A; Goren D; Fuks Z; Barenholz Y; Dagan A; Meshorer A
    Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption and tissue distribution of doxorubicin entrapped in liposomes following intravenous or intraperitoneal administration.
    Rosa P; Clementi F
    Pharmacology; 1983; 26(4):221-9. PubMed ID: 6844397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation.
    Herman EH; Rahman A; Ferrans VJ; Vick JA; Schein PS
    Cancer Res; 1983 Nov; 43(11):5427-32. PubMed ID: 6616474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity.
    Forssen EA; Tökès ZA
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1873-7. PubMed ID: 6940195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adriamycin entrapped by sulfatide-containing liposomes on ovarian tumor-bearing nude mice.
    Kojima N; Ueno N; Takano M; Yabushita H; Noguchi M; Ishihara M; Yagi K
    Biotechnol Appl Biochem; 1986 Oct; 8(5):471-8. PubMed ID: 3768148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
    Mayer LD; Tai LC; Ko DS; Masin D; Ginsberg RS; Cullis PR; Bally MB
    Cancer Res; 1989 Nov; 49(21):5922-30. PubMed ID: 2790807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
    van Hoesel QG; Steerenberg PA; Crommelin DJ; van Dijk A; van Oort W; Klein S; Douze JM; de Wildt DJ; Hillen FC
    Cancer Res; 1984 Sep; 44(9):3698-705. PubMed ID: 6744286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
    Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D
    Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.
    Parker RJ; Hartman KD; Sieber SM
    Cancer Res; 1981 Apr; 41(4):1311-7. PubMed ID: 7214320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.
    Gokhale PC; Radhakrishnan B; Husain SR; Abernethy DR; Sacher R; Dritschilo A; Rahman A
    Br J Cancer; 1996 Jul; 74(1):43-8. PubMed ID: 8679456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.